Jagsonpal Pharmaceuticals Limited has been ranked amongst top 50 pharma companies in India for March 2004. As per an independent pharmaceutical audit agency - IMS, the company's all-India ranking has jumped to 42, a company release said.

The key to market share success is the sharp focus on a select number of therapeutic groups, namely Anti-arthritics, Analgesics, Anti-inflammatories, Anti-spasmodics, Anabolic, steroids Progesterones, Anesthetics and Anti-fungals. The company has a modern WHO and GMP-certified manufacturing facility for the production of various dosage forms and bulk drugs/intermediates.

Lycored - it's antioxidant brand - registering a business of over Rs 12 crores in the first year of it's operations. It has consolidated its position within other therapeutic segments as well with brands such as Maintane, Metadec, Metabol, Doxypal-DR, Parvon range, Indocap SR (all salts), Indocap SR (Indomethacin) consistently scaling up the sales chart.

The financial performance of the company in the last quarter notched an all-time high on all parameters. Sales have gone up by a 75 per cent for the quarter ended March 2004 (Rs. 4113.14 lakhs as against Rs. 2351.15 lakhs).